Atlas Trials

Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices

Clinical trial NCT03624517 · TERMINATED

Trial details

NCT number
NCT03624517
Sponsor
Medical University of South Carolina
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Esophageal VaricesLiver CirrhosesBleeding Esophageal VaricesUpper Gastrointestinal Bleeding
Start date
2018-09-19
Primary completion
2024-12-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.